Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis
Head and neck squamous cell carcinomas (HNSCC) are among the ten most frequent types of cancer worldwide and, despite all efforts, are still diagnosed at late stages and show poor overall survival. Furthermore, HNSCC patients often experience relapses and the development of second primary tumors, as...
Guardado en:
Autores principales: | Diego Camuzi, Tatiana de Almeida Simão, Fernando Dias, Luis Felipe Ribeiro Pinto, Sheila Coelho Soares-Lima |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4f5ff1697b64249984dd71d77f21331 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
por: Re-I Chin, et al.
Publicado: (2021) -
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Adam Luginbuhl, et al.
Publicado: (2021) -
When Everything Revolves Around Internal Carotid Artery: Analysis of Different Management Strategies in Patients With Very Advanced Cancer Involving the Skull Base
por: Ester Orlandi, et al.
Publicado: (2021) -
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021) -
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Ammar Sukari, et al.
Publicado: (2015)